Moderna Made Headlight News Again


Moderna Inc (MRNA), leading vaccine maker for corona virus, announced positive result for the first stage trial. Its stock jumped +25% accordingly.

Its success is not only for this company to make more money in the future. US economy, re-opening normal activity, and saving life all depend on effectiveness of vaccine products.

Not only United States of America needs it, but the whole world is desperately looking for solution in the middle of virus crisis as well. If Moderna can keep up its result by entering into phase II and III on testing process, then it would bring faster economy recovery and slowdown death tolls significantly.

Share This Post
Have your say!

Leave a Reply